OrthoAccel Technologies, Inc. is a privately owned medical device company based in Houston, Texas. Founded in 2007, OrthoAccel Technologies is most notable for developing AcceleDent, a device which uses "micropulses" to accelerate tooth movement when used in conjunction with dental braces. The product was released in the European and Australian markets in 2009, South Korea in 2012, and the United States since 2012. OrthoAccels revenue increased approximately 300 percent from 2011 to 2012, and the following year OrthoAccel began selling AcceleDent in Canada. Around 40,000 AcceleDent units had been shipped to American practices as of June 2015. OrthoAccel Technologies, Inc. was founded in 2007 in Houston, Texas, and a prototype for AcceleDent was developed in 2008. Originally the technology was being designed for "bone metabolism by orthopedics," where "low-magnitude, high-frequency vibrations" would stimulate bone into remodeling at a faster rate. Among the original developers was Dr. Jeremy Mao, who was then on the faculty at the University of Illinois. Later redesigned to focus on the jaw, AcceleDent is non-invasive and uses the application of micropulses to accelerate orthodontic tooth movement. Early clinical testing began in 2008 in Houston. AcceleDent was marketed in Europe in 2009, with the first implementation of the device taking place in October 2009 at a private practice in the United Kingdom. In late 2009, the Australian Therapeutic Goods Administration approved AcceleDent for the Australian market on a limited basis. In February 2010, OrthoAccel received clearance from the Korean Food and Drug Administration (KFDA) to officially market AcceleDent in South Korea. The company Inno DMC was announced as the sole AcceleDent distributor in the country.